Envisioning a transformed clinical trials enterprise in the United States:: establishing an agenda for 2020: workshop summary /: Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.

Weisfeld, Neil E.; English, Rebecca A.; Claiborne, Anne B.; Institute of Medicine (U.S.).; National Academies Press (U.S.)

Envisioning a transformed clinical trials enterprise in the United States: establishing an agenda for 2020: workshop summary / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.

Weisfeld, Neil E.; English, Rebecca A.; Claiborne, Anne B.; Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.; Institute of Medicine (U.S.). Board on Health Sciences Policy.; National Academies Press (U.S.)

2012

R853.C55 E585 2012

Available Online

Formats

Format
BibTeX
MARCXML
TextMARC
MARC
DublinCore
EndNote
NLM
RefWorks
RIS

Add to Basket

Linked e-resources

Linked Resource

Online Access

Details

Title

Envisioning a transformed clinical trials enterprise in the United States: establishing an agenda for 2020: workshop summary / Neil Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy.

ISBN

9780309253154
0309253152

Publication Details

Washington : National Academies Press, 2012.

Language

English

Description

xvi, 232 p. : ill.

Call Number

R853.C55 E585 2012

Bibliography, etc. Note

Includes bibliographical references.